Opportunities In The Indian Pharmaceuticals Industry

Publication Date	June 2006
Publisher	Globus Research
Product Type	Report
Pages	55
ISBN Number	not applicable
Product Code	GLR00112

Price

£700.00
approximately: $1,023 | €767

PDF

Order above formats by FAX

Summary

With just over 2% share of the global pharmaceuticals market, India ranks as the fourth largest market in terms of volume and 13th in terms of monetary value.

In recent years the Indian pharmaceutical has been experiencing steady growth rate and the same is expected of the coming years. One of the major reasons for market growth has been new launches and to some volumes.

With the introduction of product patents by government of India, the Indian pharmaceutical has renewed the interest of global pharmaceutical giants in India. Earlier companies which were cautious about launching new products in India are now willing to launch new drugs to capitalize on this new market opportunity. Further to this India is also emerging as an alliance and outsourcing destination of choice for global pharma companies across the value chain.

This report provides all the useful information required for a busy manager/investor to tap the vast opportunities in the Indian Pharmaceuticals Sector.

Content

1. Market Overview
2. Industry Structure & Development
3. Trends In The Indian Pharmaceutical Industry
- 3.1 Crams - Contract Research & Manufacturing
- 3.2 Market Expansion Through Co-Marketing, Alliances
- 3.3 Growth Through Mergers And Acquisitions
- 3.4 Biopharmaceuticals & Value-Added Generics
4. Challenges Facing The Indian Pharmaceutical Industry
5. Key Opportunities Area
- 5.1 Marketing Opportunities
- 5.2 Outsourcing & Offshoring Opportunities
- 5.3 Manufacturing Opportunities
- 5.4 Innovation Opportunities
- 5.5 Contract Research
- 5.6 Collaborative Discovery Research
- 5.7 Clinical Research
- 5.8 Anda Research
6. SWOT Analysis
7. Brief Profiles Of Key Players In The Indian Pharmaceutical Industry
- 7.1 Ranbaxy Laboratories
- 7.2 Cipla
- 7.3 Glaxo Smithkline Beecham
- 7.4 Dr. Reddy's Laboratories
- 7.5 Nicholas Piramal
- 7.6 Aurobindo Pharma
- 7.7 Lupin
- 7.8 Cadila Healthcare
- 7.9 Sun Pharma
- 7.10 Wockhardt
- 7.11 Pfizer
- 7.12 Novartis
- 7.13 Merck
- 7.14 Eli Lilly
- 7.15 Sanofi-Aventis
8. M&A Activities In The Indian Pharmaceuticals Industry
9. Policy Initiatives
- 9.1 Recent Policy Changes In The Indian Pharmaceutical Industry
10. Outlook For Indian Pharmaceuticals Industry

About this Product

Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)

Ask a question about this product?

Need help finding the right product?

Product features / use

Scope	Comprehensive Overview
Level	General Industry Strategies
Data	Broad Market Predictions
Profiles	Profiles of Key Companies
Features	Future Consumer Trends
Extra Info	Regulatory Guidance